The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Al-Kuraishy H.M.; Al-Gareeb A.I.; Alkazmi L.; El-Bouseary M.M.; Hamad R.S.; Abdelhamid M.; Batiha G.E.-S.

Journal: Journal of Immunology Research

Publisher: Hindawi Limited

Publication Date: 20 June 2023

Volume / Issue: Volume 2023

Article No.: 5544819

ISSN: 23148861

DOI: 10.1155/2023/5544819

Scopus: View on Scopus

PubMed: 37383608

Document Type: Review

Access: All Open Access; Gold Open Access; Green Open Access


Authors and Affiliations

Al-Kuraishy H.M., Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq; Al-Gareeb A.I., Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq; Alkazmi L., Biology Department, Faculty of Applied Sciences, Umm Al-Qura University, Makkah, 21955, Saudi Arabia; El-Bouseary M.M., Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Tanta University, Tanta, Egypt; Hamad R.S., Biological Sciences Department, College of Science, King Faisal University, Al Ahsa, 31982, Saudi Arabia, Central Laboratory, Theodor Bilharz Research Institute, Giza, 12411, Egypt; Abdelhamid M., Department of Parasitology, Faculty of Veterinary Medicine, Aswan University, Aswan, 81528, Egypt; Batiha G.E.-S., Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, AlBeheira, Damanhour, 22511, Egypt


Abstract

Chronic helminth infections (CHIs) can induce immunological tolerance through the upregulation of regulatory T cells. In coronavirus disease 2019 (COVID-19), abnormal adaptive immune response and exaggerated immune response may cause immune-mediated tissue damage. Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) and CHIs establish complicated immune interactions due to SARS-CoV-2-induced immunological stimulation and CHIs-induced immunological tolerance. However, COVID-19 severity in patients with CHIs is mild, as immune-suppressive anti-inflammatory cytokines counterbalance the risk of cytokine storm. Since CHIs have immunomodulatory effects, therefore, this narrative review aimed to clarify how CHIs modulate the immunoinflammatory response in SARS-CoV-2 infection. CHIs, through helminth-derived molecules, may suppress SARS-CoV-2 entry and associated hyperinflammation through attenuation of the inflammatory signaling pathway. In addition, CHIs may reduce the COVID-19 severity by reducing the SARS-CoV-2 entry points in the initial phase and immunomodulation in the late phase of the disease by suppressing the release of pro-inflammatory cytokines. In conclusion, CHIs may reduce the severity of SARS-CoV-2 infection by reducing hyperinflammation and exaggerated immune response. Thus, retrospective and prospective studies are recommended in this regard. © 2023 Hayder M. Al-kuraishy et al.


Keywords

Animals; COVID-19; Cytokines; Helminths; Humans; Prospective Studies; Retrospective Studies; SARS-CoV-2; cryopyrin; cytokine; immunomodulating agent; inflammasome; coronavirus disease 2019; cytokine storm; disease severity; eosinopenia; helminth; helminthiasis; human; immune response; immunomodulation; nonhuman; outcome assessment; Review; Severe acute respiratory syndrome coronavirus 2; signal transduction; virus entry; animal; prospective study; retrospective study


Citation Information

Scopus Citations: 6


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer